Avaliação do risco coronário: importância das apolipoproteínas

Las Casas, Fabrício Ribeiro; Santos, Leonardo Florêncio; Thomazi, Maurício Cruz; Silva, Nilton José Carneiro da; Bussadori, Peterson Fabiano; Passos, Raphael Lanza e; Garcia, Violeta Gisela Bendezu; Faludi, André Arpad; Araújo, Daniel Branco de; Bertolami, Marcelo Chiara; Zats, Henri Paulo; Mendes, Gislaine Aparecida Nogueira; Nakamura, Yara.
RBM rev. bras. med ; 64(4): 182-189, abril. 2007. ilus, tab
Artículo en Portugués | LILACS | ID: lil-469298

Documentos relacionados

  1. Letter by Sniderman et al Regarding Article, "Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease".
  2. Response by Welsh et al to Letter Regarding Article, "Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease".
  3. Apolipoproteins and Lipoproteins in Health and Disease 2.0.
  4. Plasma cholesterol levels in infancy: a neglected resource.
  5. Metabolism of Triglyceride-Rich Lipoproteins.
  6. Cholesterol Insights and Controversies From the UK Biobank Study.
  7. Vegetarian or vegan diets and blood lipids: a meta-analysis of randomized trials.
  8. Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults.
  9. Small LDL subfractions are associated with coronary atherosclerosis despite no differences in conventional lipids.
  10. Interaction of Two Amphipathic α-Helix Bundle Proteins, ApoLp-III and ApoE 3, with the Oil-Aqueous Interface.